tiprankstipranks
Trending News
More News >
Mereo Biopharma (MREO)
:MREO
US Market

Mereo Biopharma Group Plc (MREO) Technical Analysis

Compare
611 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
3Neutral
7Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Mereo Biopharma’s (MREO) Moving Averages Convergence Divergence (MACD) indicator is 0.12, suggesting Mereo Biopharma is a Sell.
Mereo Biopharma’s (MREO) 20-Day exponential moving average is 2.60, while Mereo Biopharma’s (MREO) share price is $2.87, making it a Buy.
Mereo Biopharma’s (MREO) 50-Day exponential moving average is 2.50, while Mereo Biopharma’s (MREO) share price is $2.87, making it a Buy.

Mereo Biopharma Group Plc (MREO) Pivot Points

Jun 20, 2025, 11:30 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.68
2.71
2.76
2.79
2.83
2.86
2.91
Fibonacci
2.71
2.74
2.76
2.79
2.82
2.83
2.86
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Mereo Biopharma Group Plc (MREO) Moving Averages

Jun 20, 2025, 11:30 AM
Period
Simple
Exponential
MA5
2.79Buy
2.79Buy
MA10
2.71Buy
2.71Buy
MA20
2.52Buy
2.60Buy
MA50
2.40Buy
2.50Buy
MA100
2.51Buy
2.64Buy
MA200
3.21Sell
3.14Sell
Mereo Biopharma’s (MREO) 10-Day exponential moving average is 2.71, while Mereo Biopharma’s (MREO) share price is $2.87, making it a Buy.
Mereo Biopharma’s (MREO) 100-Day exponential moving average is 2.64, while Mereo Biopharma’s (MREO) share price is $2.87, making it a Buy.
Mereo Biopharma’s (MREO) stock price is $2.87 and Mereo Biopharma’s (MREO) 50-day simple moving average is 2.40, creating a Buy signal.
Mereo Biopharma’s (MREO) stock price is $2.87 and Mereo Biopharma’s (MREO) 100-day simple moving average is 2.51, creating a Buy signal.
Mereo Biopharma’s (MREO) stock price is $2.87 and Mereo Biopharma’s (MREO) 200-day simple moving average is 3.21, creating a Sell signal.

Mereo Biopharma Group Plc (MREO) Technical Indicators

Jun 20, 2025, 11:30 AM
Name
Value
Implied Action
RSI (14)
66.04
Neutral
STOCH (9,6)
85.65
Sell
STOCHRSI (14)
92.07
Sell
MACD (12,26)
0.12
Sell
ADX (14)
27.19
Neutral
Williams %R
-4.88
Sell
CCI (14)
104.01
Sell
ATR (14)
0.15
-
Ultimate Oscillator
51.37
Neutral
ROC
29.86
Buy
Mereo Biopharma’s (MREO) Relative Strength Index (RSI) is 66.04, creating a Neutral signal.
Mereo Biopharma’s (MREO) Trend Strength Indicator (ADX) is 27.19, creating a Neutral signal.
Mereo Biopharma’s (MREO) Commodity Channel Index (CCI) is 104.01, creating a Sell signal.
Mereo Biopharma’s (MREO) Price Rate of Change (ROC) is 29.86, creating a Buy signal.

FAQ

Is MREO a Buy, Hold, or Sell?
Based on MREO’s technical indicators, MREO is a Buy.
    What is MREO’s RSI (14)?
    MREO’s RSI (14) is 66.04, which suggests MREO is a Neutral.
      What is MREO’s MACD?
      MREO’s MACD is 0.12, which suggests MREO is a Sell.
        What is MREO’s 5-day moving average?
        MREO’s 5-day moving average is 2.79, which suggests MREO is a Buy.
          What is MREO’s 20-day moving average?
          MREO 20-day moving average is 2.52, which suggests MREO is a Buy.
            What is MREO’s 50-day moving average?
            MREO’s 50-day moving average is 2.40, which suggests MREO is a Buy.
              What is MREO’s 200-day moving average?
              MREO’s 200-day moving average is 3.21, which suggests MREO is a Sell.
                What is MREO’s Williams % R (14)?
                MREO’s Williams % R (14) is -4.88, which suggests MREO is a Sell.
                  What is MREO’s CCI (14)?
                  MREO’s CCI (14) is 104.01, which suggests MREO is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis